Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BURNING ROCK BIOTECH LIMITED

(BNR)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Burning Rock Biotech Limited Reiterates Earnings Guidance for the Full Year 2021 and Provides Guidance for the Second Half of 2021

05/25/2021 | 07:12am EDT

Burning Rock Biotech Limited reiterated earnings guidance for the full year 2021. The company announced that assuming there are no additional COVID-19 related restrictions imposed in China, which might negatively affect patient volumes and cancer testing, its full year 2021 revenues is expected to be approximately RMB 610 million (USD 93.1 million), implying a 41.9% growth over full year 2020. The company expects a second half heavy compared to first half light of the year.


© S&P Capital IQ 2021
All news about BURNING ROCK BIOTECH LIMITED
09/14BURNING ROCK BIOTECH : and CStone Pharmaceuticals reached a strategic collaborat..
PU
09/14BURNING ROCK BIOTECH : deepens cooperation with Illumina to promote development ..
PU
09/14BURNING ROCK BIOTECH : initiates the first prospective, multi-center pan-cancer ..
PU
09/14BURNING ROCK BIOTECH : Dx Launches Magnis BR to Innovate Total Process Automatio..
PU
09/14BURNING ROCK BIOTECH : announces the completion of the Series C financing of RMB..
PU
09/14BURNING ROCK BIOTECH : China's first NGS cancer testing kit made by Burning Rock..
PU
09/14BURNING ROCK BIOTECH : Dx Honored with 2018 Guangzhou Hi-tech “Unicorn&rdq..
PU
09/14BURNING ROCK BIOTECH : Dx Certified by the Certification of ISO 13485 Quality Ma..
PU
09/14BURNING ROCK BIOTECH : and Illumina Collaborate on Molecular Diagnostics for Onc..
PU
08/31SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Tuesday
MT
More news
Analyst Recommendations on BURNING ROCK BIOTECH LIMITED
More recommendations
Financials
Sales 2021 503 M 77,8 M 77,8 M
Net income 2021 -395 M -61,1 M -61,1 M
Net cash 2021 1 443 M 223 M 223 M
P/E ratio 2021 -34,8x
Yield 2021 -
Capitalization 13 796 M 2 134 M 2 134 M
EV / Sales 2021 24,5x
EV / Sales 2022 17,9x
Nbr of Employees 938
Free-Float 72,4%
Chart BURNING ROCK BIOTECH LIMITED
Duration : Period :
Burning Rock Biotech Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BURNING ROCK BIOTECH LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 131,96 CNY
Average target price 211,13 CNY
Spread / Average Target 60,0%
EPS Revisions
Managers and Directors
Yu Sheng Han Chairman & Chief Executive Officer
Leo Li Chief Financial Officer & Director
Zhi Hong Zhang Chief Technology Officer
Shao Kun Chuai Chief Operating Officer & Director
Wendy Hayes Independent Director
Sector and Competitors